There have been several recent developments in the diagnosis, risk stratifi
cation and treatment of acute ischaemic coronary syndrome (AICS). These inc
lude the use of troponins for the diagnosis and risk stratification of AICS
. The use of glycoprotein IIb/IIIa inhibitors and angioplasty with stenting
has altered the prognosis associated with AICS. This brief review consider
s these issues.